The 25th Annual International AF Symposium on January 23-25, 2020 will be held at the Gaylord National Hotel, Washington, DC. This intensive three-day symposium brings together the world’s leading medical scientists to share in a highly interactive environment the most recent advances in the field of atrial fibrillation.
Omega will be showcasing FluoroShield™, the first AI Image-guided system to reduce dose area product during interventional procedures. The U.S. Food and Drug Administration granted Omega Medical Imaging clearance through the 510(k) process. Clinical studies have shown Omega’s AI image-guided systems to reduce dose area product (DAP) by up to ~84%*; leading to less radiation exposure that may reduce the risk of cancer, skin burns, and other harmful side effects. Learn more.
If you are attending, be sure to stop by the exhibitor area: Booth 123
About Omega Medical Imaging
Since 1991 Omega’s engineers, designers, craftsmen, and technicians have been building the most reliable and technically advanced Fluoro and Cine imaging systems, and now the world’s only artificial intelligence image-guided system for Interventional procedures. Omega is the only manufacturer in the world that specializes in systems designed from the ground up for special therapeutic procedures. Our list of growing references includes prestigious physicians, healthcare systems, and providers around the world.
